Invivyd, Inc. (IVVD)
$0.67-6.94%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $197M
- Beta
- 0.71
- P/E (TTM)
- -2.05
- Short % float
- 13.55%
- Days to cover
- 3.6
- SI change
- +10.8%
- 1W
- -20.24%
- 1M
- -15.19%
- vs SPY 1W
- -20.66%
- vs SPY 1M
- -17.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on IVVD?
- LOPJLB’s latest quantitative signal on Invivyd, Inc. (IVVD) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is IVVD in?
- Invivyd, Inc. (IVVD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Invivyd, Inc. (IVVD) do?
- Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management…